SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar

2024-10-31 (lavoz.com.ar)
EU fines Teva 460 million euros for trying to protect patent for sclerosis medicine
EU fines Teva 460 million euros for trying to protect patent for sclerosis medicine
Read more